523620 logo

Phaarmasia Limited Stock Price

BSE:523620 Community·₹487.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

523620 Share Price Performance

₹71.44
42.13 (143.74%)
₹71.44
42.13 (143.74%)
Price ₹71.44

523620 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with acceptable track record.

3 Risks
2 Rewards

Phaarmasia Limited Key Details

₹449.1m

Revenue

₹316.6m

Cost of Revenue

₹132.5m

Gross Profit

-₹45.1m

Other Expenses

₹177.5m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
26.01
29.50%
39.54%
0%
View Full Analysis

About 523620

Founded
1981
Employees
36
CEO
Yallapragada Naga Rao
WebsiteView website
www.phaarmasia.in

Phaarmasia Limited manufactures and sells oral contraceptive pills and iron tablets in India. It offers hormone products, including mifepristone and misoprostaol, desogestrel and ethinyl estradiol, estradiol valerate, levonorgestrel and ethinyl estradiol, medroxyprogesterone acetate, cabergoline, clomiphene citrate, levonorgestrel, progesterone, fluoxymesterone, liothyronine sodium, chlorodehydromethyltestosterone, liothyronine sodium, oxandrolone tablets, testosterone cypionate, methenolone enanthate, drostanolone, testosterone, trenbolone, and stanozolol cypionate injections. The company provides herbal products, such as herbal toothpaste, cough and sore throat reliver, and mouth ulcer gel under the Smyle brand name. Phaarmasia Limited was incorporated in 1981 and is based in Hyderabad, India.

Recent 523620 News & Updates

Recent updates

No updates